Metformin, one of the primary insulin-sensitizing medications prescribed to patients with Type 2 Diabetes Mellitus (T2DM), improved memory in patients with AD and no history of diabetes or pre-diabetes [93]. This evidence concerns the gene INS and Alzheimer disease.